Enhancing cervical cancer prevention in Nigeria

Enhancing cervical cancer prevention in Nigeria

Abuja Adenike Olayemi states Nigeria’s cervical cancer screening program conserved her life: “I can not picture what might have occurred if I had actually refrained from doing the screening and opted for treatment.”

Olayemi, 43, who resides in Ondo State, was amongst 667 ladies who evaluated favorable for the human papillomavirus (HPV) and went through treatment to prevent cervical cancer throughout a project in 2023, moneyed by the Susan Thompson Buffet Foundation and supported by World Health Organization (WHO) in the African Region.

The assistance to 5 states, Anambra, Ondo, Kebbi, Niger and Ekiti, made it possible for regular cervical cancer secondary avoidance services throughout main health care centers, benefiting 21 851 ladies. They went through visual assessments with acetic acid (VAI), a basic, safe and economical option to a pap smear. Utilizing VIA a health employee performs a visual evaluation of the cervix to identify precursors of cervical cancer following the application of acetic acid.

Pap smears work tools to spot unusual cells before they advance to cancer, however access to this service is restricted, particularly for susceptible ladies residing in remote backwoods.

Ilemobayo Wuraola, a nurse at the household preparation center at Arakale Health Centre in Akure, in Ondo State, states: “The program supplied by the federal government and its partners at main health centers has actually informed lots of people about cervical cancer, and brought livesaving services better to individuals.”

In line with the Global Strategy to remove cervical cancer by 2030, WHO, Gavi, the Vaccine Alliance and partners, in partnership with the Government of Nigeria, established and carried out a multi-pronged avoidance technique to safeguard the lives of ladies and ladies from the fatal illness. This consists of the rollout of a mass HPV vaccination project targeting ladies aged 9 to 14 years to get a single dosage of the vaccine in 16 states.

In between October 2023 and January 2024, 4.95 million ladies were immunized versus HPV.

Cervical cancer is among the most typical cancers amongst ladies worldwide, with HPV accountable for almost all cases. HPV is a sexually transmitted infection, with almost every sexually go-getter at threat of direct exposure. While lots of HPV infections clear up naturally, specific stress can result in cervical, anal, oropharyngeal and other cancers, if left unattended.

Cervical cancer is avoidable through the HPV vaccine, while routine screening for precancerous conditions can assist early detection to lower cases and deaths by enabling prompt treatment and efficient management.

“We applaud the federal government’s efforts to present the HPV vaccine and set in movement strategies to present the 2nd stage of immunization to the staying 21 states,” states WHO Country Representative in Nigeria, Dr Walter Kazadi Mulombo.

“Let us honour the memory of those lost to HPV-related health problems by restoring our dedication to vaccination, screening, early medical diagnosis and treatment,” he includes.

Find out more

Leave a Reply

Your email address will not be published. Required fields are marked *